Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement
Teva's flagship drug Austedo scores new approval at the FDA
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
Today's News: FBI Raids NY Yeshiva; Layoffs at Israel's Teva Pharmaceuticals; and more - Tablet Magazine
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva made smart decision to move to us: Allergan CEO
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva to acquire Allergan for $40B
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Is Teva Pharmaceutical Industries (NYSE:TEVA) A Risky Investment? - Simply Wall St News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva shares surge after announcing global opioid settlement
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
New York could get $524M under opioid settlements with Teva - ABC News
